author-photo

Ingrid Hernandez

Johnson & Johnson Pharmaceutical Research and Development

1

Papers

18

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

A Phase I Study of Tipifarnib in Combination with Imatinib Mesylate (IM) for Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Who Failed IM Therapy.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (18)